aluates Reports

$ 0.0

Automative

Global PD-L1 Biomarker Testing Market Insights, Forecast to 2030

Published Date: August 2024

Report Code: QYRE-Auto-6F9402

Global PD L1 Biomarker Testing Market Size Status and Forecast 2022

BUY CHAPTERS

Global PD-L1 Biomarker Testing Market Insights, Forecast to 2030

Code: QYRE-Auto-6F9402

Report

August 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Roche

PD-L1 Biomarker Testing Market Size

The global PD-L1 Biomarker Testing market is projected to grow from US$ 2088 million in 2024 to US$ 14870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 38.7% during the forecast period.

PD-L1 Biomarker Testing Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.

PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.

Market Analysis and Insights: Global PD-L1 Biomarker Testing Market

The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.

PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.

North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.

Report Covers:

This report presents an overview of global market for PD-L1 Biomarker Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of PD-L1 Biomarker Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for PD-L1 Biomarker Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PD-L1 Biomarker Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global PD-L1 Biomarker Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for PD-L1 Biomarker Testing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of PD-L1 Biomarker Testing Market Report

Report Metric	Details
Report Name	PD-L1 Biomarker Testing Market
Accounted market size in 2024	US$ 2088 million
Forecasted market size in 2030	US$ 14870 million
CAGR	38.7
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	PD-L1 (22C3) PD-L1(28-8) PD-L1 (SP142) PD-L1 (SP263) Other
Segment by Application	Hospital Diagnostic Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of PD-L1 Biomarker Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 Biomarker Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-L1 Biomarker Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is PD-L1 Biomarker Testing Market growing?

Ans: The PD-L1 Biomarker Testing Market witnessing a CAGR of 38.7 during the forecast period 2024-2030.

What is the PD-L1 Biomarker Testing Market size in 2030?

Ans: The PD-L1 Biomarker Testing Market size in 2030 will be US$ 14870 million.

What is the PD-L1 Biomarker Testing Market share by application?

Ans: The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.

What is the PD-L1 Biomarker Testing Market share by region?

Ans: North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019.

Who are the main players in the PD-L1 Biomarker Testing Market report?

Ans: The main players in the PD-L1 Biomarker Testing Market are Agilent Technologies, Roche

What are the Application segmentation covered in the PD-L1 Biomarker Testing Market report?

Ans: The Applications covered in the PD-L1 Biomarker Testing Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the PD-L1 Biomarker Testing Market report?

Ans: The Types covered in the PD-L1 Biomarker Testing Market report are PD-L1 (22C3), PD-L1(28-8), PD-L1 (SP142), PD-L1 (SP263), Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 PD-L1 (22C3)

1.2.3 PD-L1(28-8)

1.2.4 PD-L1 (SP142)

1.2.5 PD-L1 (SP263)

1.2.6 Other

1.3 Market by Application

1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global PD-L1 Biomarker Testing Market Perspective (2019-2030)

2.2 Global PD-L1 Biomarker Testing Growth Trends by Region

2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2019-2024)

2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030)

2.3 PD-L1 Biomarker Testing Market Dynamics

2.3.1 PD-L1 Biomarker Testing Industry Trends

2.3.2 PD-L1 Biomarker Testing Market Drivers

2.3.3 PD-L1 Biomarker Testing Market Challenges

2.3.4 PD-L1 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue PD-L1 Biomarker Testing by Players

3.1.1 Global PD-L1 Biomarker Testing Revenue by Players (2019-2024)

3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2019-2024)

3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of PD-L1 Biomarker Testing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio

3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2023

3.5 Global Key Players of PD-L1 Biomarker Testing Head office and Area Served

3.6 Global Key Players of PD-L1 Biomarker Testing, Product and Application

3.7 Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 PD-L1 Biomarker Testing Breakdown Data by Type

4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2019-2024)

4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030)

5 PD-L1 Biomarker Testing Breakdown Data by Application

5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2019-2024)

5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America PD-L1 Biomarker Testing Market Size (2019-2030)

6.2 North America PD-L1 Biomarker Testing Market Size by Type

6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2019-2024)

6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2025-2030)

6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2019-2030)

6.3 North America PD-L1 Biomarker Testing Market Size by Application

6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2019-2024)

6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2025-2030)

6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2019-2030)

6.4 North America PD-L1 Biomarker Testing Market Size by Country

6.4.1 North America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2019-2024)

6.4.3 North America PD-L1 Biomarker Testing Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe PD-L1 Biomarker Testing Market Size (2019-2030)

7.2 Europe PD-L1 Biomarker Testing Market Size by Type

7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2019-2024)

7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2025-2030)

7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2019-2030)

7.3 Europe PD-L1 Biomarker Testing Market Size by Application

7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2019-2024)

7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2025-2030)

7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2019-2030)

7.4 Europe PD-L1 Biomarker Testing Market Size by Country

7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024)

7.4.3 Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China PD-L1 Biomarker Testing Market Size (2019-2030)

8.2 China PD-L1 Biomarker Testing Market Size by Type

8.2.1 China PD-L1 Biomarker Testing Market Size by Type (2019-2024)

8.2.2 China PD-L1 Biomarker Testing Market Size by Type (2025-2030)

8.2.3 China PD-L1 Biomarker Testing Market Share by Type (2019-2030)

8.3 China PD-L1 Biomarker Testing Market Size by Application

8.3.1 China PD-L1 Biomarker Testing Market Size by Application (2019-2024)

8.3.2 China PD-L1 Biomarker Testing Market Size by Application (2025-2030)

8.3.3 China PD-L1 Biomarker Testing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia PD-L1 Biomarker Testing Market Size (2019-2030)

9.2 Asia PD-L1 Biomarker Testing Market Size by Type

9.2.1 Asia PD-L1 Biomarker Testing Market Size by Type (2019-2024)

9.2.2 Asia PD-L1 Biomarker Testing Market Size by Type (2025-2030)

9.2.3 Asia PD-L1 Biomarker Testing Market Share by Type (2019-2030)

9.3 Asia PD-L1 Biomarker Testing Market Size by Application

9.3.1 Asia PD-L1 Biomarker Testing Market Size by Application (2019-2024)

9.3.2 Asia PD-L1 Biomarker Testing Market Size by Application (2025-2030)

9.3.3 Asia PD-L1 Biomarker Testing Market Share by Application (2019-2030)

9.4 Asia PD-L1 Biomarker Testing Market Size by Region

9.4.1 Asia PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia PD-L1 Biomarker Testing Market Size by Region (2019-2024)

9.4.3 Asia PD-L1 Biomarker Testing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction

11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.1.5 Agilent Technologies Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche PD-L1 Biomarker Testing Introduction

11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.2.5 Roche Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies

Roche

List of Tables

Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of PD-L1 (22C3)

Table 3. Key Players of PD-L1(28-8)

Table 4. Key Players of PD-L1 (SP142)

Table 5. Key Players of PD-L1 (SP263)

Table 6. Key Players of Other

Table 7. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2019-2024)

Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2025-2030)

Table 13. PD-L1 Biomarker Testing Market Trends

Table 14. PD-L1 Biomarker Testing Market Drivers

Table 15. PD-L1 Biomarker Testing Market Challenges

Table 16. PD-L1 Biomarker Testing Market Restraints

Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global PD-L1 Biomarker Testing Revenue Share by Players (2019-2024)

Table 19. Global Top PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)

Table 20. Global PD-L1 Biomarker Testing Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of PD-L1 Biomarker Testing, Headquarters and Area Served

Table 23. Global Key Players of PD-L1 Biomarker Testing, Product and Application

Table 24. Global Key Players of PD-L1 Biomarker Testing, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2019-2024)

Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2025-2030)

Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global PD-L1 Biomarker Testing Revenue Share by Application (2019-2024)

Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global PD-L1 Biomarker Testing Revenue Share by Application (2025-2030)

Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 48. China PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 49. China PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)

Table 50. China PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 51. China PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia PD-L1 Biomarker Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia PD-L1 Biomarker Testing Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 66. Agilent Technologies Company Details

Table 67. Agilent Technologies Business Overview

Table 68. Agilent Technologies PD-L1 Biomarker Testing Product

Table 69. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 70. Agilent Technologies Recent Developments

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche PD-L1 Biomarker Testing Product

Table 74. Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 75. Roche Recent Developments

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global PD-L1 Biomarker Testing Market Share by Type: 2023 VS 2030

Figure 3. PD-L1 (22C3) Features

Figure 4. PD-L1(28-8) Features

Figure 5. PD-L1 (SP142) Features

Figure 6. PD-L1 (SP263) Features

Figure 7. Other Features

Figure 8. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global PD-L1 Biomarker Testing Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Diagnostic Center Case Studies

Figure 12. Others Case Studies

Figure 13. PD-L1 Biomarker Testing Report Years Considered

Figure 14. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global PD-L1 Biomarker Testing Market Share by Region: 2023 VS 2030

Figure 17. Global PD-L1 Biomarker Testing Market Share by Players in 2023

Figure 18. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2023

Figure 20. North America PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America PD-L1 Biomarker Testing Market Share by Type (2019-2030)

Figure 22. North America PD-L1 Biomarker Testing Market Share by Application (2019-2030)

Figure 23. North America PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 24. United States PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe PD-L1 Biomarker Testing Market Share by Type (2019-2030)

Figure 28. Europe PD-L1 Biomarker Testing Market Share by Application (2019-2030)

Figure 29. Europe PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 30. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China PD-L1 Biomarker Testing Market Share by Type (2019-2030)

Figure 38. China PD-L1 Biomarker Testing Market Share by Application (2019-2030)

Figure 39. Asia PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia PD-L1 Biomarker Testing Market Share by Type (2019-2030)

Figure 41. Asia PD-L1 Biomarker Testing Market Share by Application (2019-2030)

Figure 42. Asia PD-L1 Biomarker Testing Market Share by Region (2019-2030)

Figure 43. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 53. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions